Topics

#VisualAbstract: Teprotumumab for the Treatment of Active Thyroid Eye Disease

14:51 EST 14 Feb 2020 | 2 Minute Medicine

1. In this phase 3 trial, patients with thyroid eye disease who received teprotumumab were far more likely to demonstrate a proptosis response compared to those who received placebo. On average, those who received teprotumumab also experienced a greater magnitude of response. 2. Patients in the teprotumumab group also experienced superior outcomes with regard to […]
Source: 2 Minute Medicine

Original Article: #VisualAbstract: Teprotumumab for the Treatment of Active Thyroid Eye Disease

NEXT ARTICLE

More From BioPortfolio on "#VisualAbstract: Teprotumumab for the Treatment of Active Thyroid Eye Disease"

Quick Search

Relevant Topic

Thyroid Disorders
The thyroid is a butterfly-shaped gland in the neck, just above thecollarbone and is an endocrine gland that make hormones. These Thyroid hormones control the rate of many activities in the body, including how fast the body burns calories and how fast th...